The Size of the Europe Pharmaceutical Membrane Filtration Market is valued at USD 1.89 billion in 2019 and is likely to grow at a CAGR of 10.1% to reach USD 3.05 billion by 2024 during the forecast period 2019-2024.
Industrial approaches for the channelling of substances betwixt two segments by the use of permeable membranes is covered by membrane technology. In general, membrane technology is used in machine-driven separation processes aimed at separating gaseous or liquid streams. Membrane separation processes utilize less energy as compared to straight thermal separation processes such as distillation, sublimation or crystallization due to their functioning without heating. Either segments (permeate and retentate) can be utilized for separation which is purely physical.
Readily acceptance of the nanofiltration technology, steadily rising biopharmaceutical industry, as well as rapid growth in generics production are the factors driving this market. Stringent regulatory requirements and high prices are hindering the growth of this market.
Europe Pharmaceutical Membrane Filtration Market has been segmented and sub-segmented into the following categories
On the basis of product, the MCE membrane filters category is estimated to account for the biggest market share in 2016. This is majorly attributed to the high adoption rate of membrane filtration products.
On the basis of technique, the microfiltration category is estimated to grow at the highest CAGR during the aforementioned forecast period. This can be attributed to the high rates of production of pharmaceutical products and drugs.
On the basis of application, the final product processing category is estimated to growth at the highest rate during the aforementioned forecast period.
Promising Companies dominating the Europe Pharmaceutical Membrane Filtration Market profiled in this report are Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.)
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 MCE Membrane Filters
5.1.2 Coated Cellulose Acetate Membrane Filters
5.1.3 Nylon Membrane Filters
5.1.4 PTFE Membrane Filters
5.1.5 PVDF Membrane Filters
5.1.6 Other Membrane Filters
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Technique
5.2.1 Microfiltration
5.2.2 Ultrafiltration
5.2.3 Nanofiltration
5.2.4 Crossfiltration
5.2.5 Reverse Osmosis
5.2.6 Ion Exchange
5.2.7 Y-o-Y Growth Analysis, By Technique
5.2.8 Market Attractiveness Analysis, By Technique
5.2.9 Market Share Analysis, By Technique
5.3 Application
5.3.1 Final Product Processing
5.3.2 Raw Material Filtration
5.3.3 Cell Separation
5.3.4 Water Purification
5.3.5 Air Purification
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technique
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technique
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technique
6.1.5.4 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Novasep
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA (Germany)
8.3 GE Healthcare Company (U.K.)
8.4 Pall Corporation (U.S.)
8.5 Sartorius Stedim Biotech Group (France)
8.6 Alfa Laval (Sweden)
8.7 Graver Technologies
8.8 LLC (U.S.)
8.9 Koch Membrane Systems Inc. (U.S.)
8.10 GEA Group (Germany)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
